4NWM | Crystal structure of Bruton agammaglobulinemia tyrosine kinase complexed with BMS-809959 aka 4-tert-butyl-n-[2-me thyl-3-(6-{[4-(morpholine-4-carbonyl)phenyl]amino}-9h- purin-2-yl)phenyl]benzamide | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Muckelbauer, J.K. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.03 | ||||||||||||
ligand | 2P5, OCS | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Purine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors for autoimmune diseases., Shi Q, Tebben A, Dyckman AJ, Li H, Liu C, Lin J, Spergel S, Burke JR, McIntyre KW, Olini GC, Strnad J, Surti N, Muckelbauer JK, Chang C, An Y, Cheng L, Ruan Q, Leftheris K, Carter PH, Tino J, De Lucca GV, Bioorg Med Chem Lett. 2014 May 1;24(9):2206-11. doi: 10.1016/j.bmcl.2014.02.075. , Epub 2014 Mar 13. PMID:24685542 |
Data retrieval |
View 4NWM in 3D |
Visual 3D analysis of 4NWM |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4NWM |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |